First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1.
Kathryn E StephensonMichael C KeeferCatherine A BunceDoreen FrancesPeter AbbinkLori F MaxfieldGeorge H NeubauerJoseph NkololaLauren PeterChristopher LaneHarriet ParkCarl VerlindeAngela LombardoChristopher YallopMenzo HavengaPatricia FastJohn TreanorDan H BarouchPublished in: PloS one (2018)
ClinicalTrials.gov NCT02366013.